IP Library Granted Patent US 11,826,990
Granted Patent B2
US 11,826,990 · App. 16/957,850 · Granted Nov 28, 2023

Multi-layer articles and methods for producing the same

Inventor: Chengjie Fu (Shanghai, CN)
Assignees: Baxter International Inc.; Baxter Healthcare SA
B32B27/08B32B7/04B32B27/304B32B27/308B32B27/32B32B37/0038B32B2250/02B32B2250/03B32B2250/246B32B2323/04B32B2323/10B32B2327/06B32B2333/08B32B2333/12B32B2535/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,826,990
App. No.
16/957,850
Granted
Nov 28, 2023
Kind
B2
Abstract

The present disclosure provides multi-layer articles that comprise a polyolefin component and a polymer blend attached to the polyolefin component, wherein the polymer blend includes (1) a propylene and α-olefin copolymer in an amount from about 15% to about 70% by weight of the polymer blend, and (2) a carbon monoxide-containing polyolefin-based copolymer in an amount from about 25% to about 85% by weight of the polymer blend. The polymer blend has an extractables fraction with pH higher than 5. Also provided are methods of bonding a first layer comprising polyvinyl chloride to a second layer comprising the disclosed polymer blend.

Claims (25)

1. A multi-layer article comprising:

a polyolefin component; and

a polymer blend attached to the polyolefin component, wherein the polymer blend includes (1) a propylene and α-olefin copolymer in an amount from about 15% to about 55% by weight of the polymer blend, and (2) a carbon monoxide-containing polyolefin-based copolymer comprising an ethylene-n-butyl acrylate-carbon monoxide copolymer in an amount from about 45% to about 83% by weight of the polymer blend, and wherein the polymer blend has an extractable fraction having a pH higher than 5 when an extraction is performed according to Chinese Standard YBB00242004-2015 and the pH is measured in accordance with General Rule 0631 of Chinese Pharmacopoeia 2015, Part 4.

2. The multi-layer article of claim 1 , wherein the polymer blend is attached to the polyolefin component by overmolding.

3. The multi-layer article of claim 1 , wherein the carbon monoxide-containing polyolefin-based copolymer is in an amount from about 45% to about 80% by weight of the polymer blend.

4. The multi-layer article of claim 1 , wherein the carbon monoxide-containing polyolefin-based copolymer is in an amount from about 50% to about 70% by weight of the polymer blend.

5. The multi-layer article of claim 1 , wherein the propylene and α-olefin copolymer is in an amount from about 15% to about 50% by weight of the polymer blend.

6. The multi-layer article of claim 1 , wherein the propylene and α-olefin copolymer is in an amount from about 25% to about 45% by weight of the polymer blend.

7. The multi-layer article of claim 1 , wherein the propylene and α-olefin copolymer has an α-olefin content of from about 1% to about 10% by weight of the copolymer.

8. The multi-layer article of claim 1 comprising a third layer attached to the second layer opposite the first layer, wherein the third layer comprises a polyolefin.

9. A multi-layer article comprising:

a first layer comprising polyvinyl chloride; and

a second layer attached to the first layer, wherein the second layer comprises a polymer blend including (1) a propylene and α-olefin copolymer in an amount from about 15% to about 70% by weight of the polymer blend, and (2) an ethylene-n-butyl acrylate-carbon monoxide copolymer in an amount from about 25% to about 85% by weight of the polymer blend.

10. The multi-layer article of claim 9 , wherein the ethylene-n-butyl acrylate-carbon monoxide copolymer is in an amount from about 45% to about 80% by weight of the polymer blend.

11. The multi-layer article of claim 9 , wherein the ethylene-n-butyl acrylate-carbon monoxide copolymer is in an amount from about 50% to about 70% by weight of the polymer blend.

12. The multi-layer article of claim 9 , wherein the propylene and α-olefin copolymer is in an amount from about 15% to about 50% by weight of the polymer blend.

13. The multi-layer article of claim 9 , wherein the propylene and α-olefin copolymer is in an amount from about 25% to about 45% by weight of the polymer blend.

14. The multi-layer article of claim 9 , wherein the propylene and α-olefin copolymer has an α-olefin content of from about 1% to about 10% by weight of the copolymer.

15. The multi-layer article of claim 9 , wherein the polymer blend includes an ethylene-methyl acrylate copolymer in an amount from about 2% to about 8% by weight of the polymer blend.

16. The multi-layer article of claim 9 comprising a third layer attached to the second layer opposite the first layer, wherein the third layer comprises a polyolefin.

17. A method of bonding a first polyvinyl chloride component to a second polyolefin component, the method comprising:

attaching a polymer blend to the second polyolefin component, wherein the polymer blend includes (1) a propylene and α-olefin copolymer in an amount from about 15% to about 70% by weight of the polymer blend, and (2) a carbon monoxide-containing polyolefin-based copolymer comprising an ethylene-n-butyl acrylate-carbon monoxide copolymer in an amount from about 25% to about 85% by weight of the polymer blend, and wherein the polymer blend has an extractable fraction having a pH higher than 5 when an extraction is performed according to Chinese Standard YBB00242004-2015 and the pH is measured in accordance with General Rule 0631 of Chinese Pharmacopoeia 2015, Part 4; and

solvent bonding the first polyvinyl chloride component to the polymer blend.

18. The method of claim 17 , wherein the first polyvinyl chloride component and the polymer blend are autoclave bonded.

19. The method of claim 17 comprising autoclave bonding a third polyolefin component to the second polyolefin component opposite the first polyvinyl chloride component.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 073413/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073438/0790 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2021
From: FU, CHENGJIE
To: BAXTER HEALTHCARE (SUZHOU) CO. LTD.
Reel/Frame 056142/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2021
From: BAXTER HEALTHCARE (SUZHOU) CO. LTD.
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 056144/0201 →
Continuity (1)
Related Publication 20210053321A1 · Feb 25, 2021
Cited By (1)
US 12,264,235